Sedano, Rosa L.
HRN: 28-74-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/04/2026
04/11/2026
IV
750mg
Q8h
ILEUS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: